ecampus

The US (Food and Drug Administration) (Food and Drug Administration) has asked makers of all anti depression medicate drugs to change the existing “black box” labels on their products to warn about increased risk of suicidality (suicidal thinking and behaviour) among young adults aged 18 to 24 in the first few weeks of a [...]

[Read more]

Patients requesting specific drugs can have a profound effect on physicians prescribing drugs for major depression, according to a new meditate in the April 27 issue of JAMA.
“Spending on direct-to-consumer (DTC) advertising of prescription drugs in the United States totaled $3.2 billion in 2003,” the authors provide as background information. “Critics [...]

[Read more]

Consumer ads for a class of anti depression medicates called SSRIs often claim that depression is due to a chemical imbalance in the brain, and that SSRIs correct this imbalance, but these claims are not supported by scientific evidence, say researchers in PLoS Medicine.
Although scientists in the 1960s suggested that depression may [...]

[Read more]

Adding a medication to a standard pharmacomedical care regimen for major depressive disorder in the elderly improves chances of recovery in those who do not adequately respond to the first-course medical care or who relapse from it, finds a University of Pittsburgh School of Medicine meditate published in the June issue of the [...]

[Read more]

Researchers from Boston University’s Slone Epidemiology Center have found that certain selective serotonin reuptake inhibitors anti depression medicates do not appear to increase the risk for most kinds of birth defects. The findings, published in the New England Journal of Medicine, suggest that individual SSRIs may increase the risk for some specific defects, but [...]

[Read more]

A review of 293 studies that assessed 12 commonly prescribed second-generation anti depression medicates found no significant differences between the drugs for the pharmacomedical care of acute-phase depression, according to a report by the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.
However, side effects among the drugs varied, causing [...]

[Read more]

For depressed group with bipolar disorder who are taking a mood stabilizer, adding an anti depression medicate medication is no more effective than a placebo (sugar pill), according to results published online on March 28, generic viagra 50 mgin the New England Journal of Medicine. The results are part of the large-scale, multi-site Systematic [...]

[Read more]

A meta-analysis of previously published studies examining the use of nonhormonal therapies for treating menopausal hot flashes finds that some therapies are effective, but less so than estrogen, and have possible adverse effects that may restrict their use, according to an article in the May 3 issue of JAMA.
Hot flashes are the [...]

[Read more]

A Canadian meditate suggests that group over 50 on a certain type of anti depression medicate are twice as likely to suffer bone fractures.
The meditate is published in the Archives of Internal Medicine.
The research was conducted by a team of scientists from various Canadian research centres.
They [...]

[Read more]

There is insufficient evidence to determine if current gene-based agsdhfgdfs intended to personalize the dose of drugs in a class of drugs called selective serotonin reuptake inhibitors (SSRIs) improve patient outcomes or aid in pharmacomedical care decisions in the clinical setting, according to a new evidence report supported by a collaboration of the Agency [...]

[Read more]